Patients who participated in the clinical trial of the new therapy not only experienced reduction in NF1 and plexiform neurofibromas tumor volume, but also reported

This column is the first in a 4-part series from Dr. Taeho Jo titled "AI in Medicine: From Nobel Discoveries to Clinical Frontiers". 

A team of researchers at the Indiana University School of Medicine is investigating a bacterial connection between the gut microbiome and microglia actions in Alzheimer’s

At the heart of Dr. Yuan Liu's research lies a powerful approach: integrating molecular data with real-world clinical information. 

Researchers from the Indiana University School of Medicine are investigating why individuals who have experienced traumatic brain injuries — whether from a single or repeated

IU School of Medicine's Selena Wang is trying find the answer to many complexities of the brain and Alzheimer's disease using artificial intelligence.

Jignesh Tailor hopes his studies into the role of NF2 gene mutation in neural stem cell differentiation failure and tumorigenesis will lead to new therapeutics

ALS Awareness Month: Brian Pierchala, PhD, is growing ALS research at IU School of Medicine through the Motoneuron Club and collaborative science.

Indiana patients are among the first people in the country to receive new disease-modifying drugs for Alzheimer's disease, contributing to the work of IU School